Suzuki, Ryoko
Wei, Xiong
Allen, Pamela K.
Welsh, James W.
Cox, James D.
Komaki, Ritsuko
Lin, Steven H.
Funding for this research was provided by:
National Institutes of Health (P30 CA 016672)
Article History
Received: 10 April 2018
Accepted: 18 December 2018
First Online: 29 December 2018
Ethics approval and consent to participate
: This retrospective study was approved by the Institutional Review Board of The University of Texas MD Anderson Cancer Center.
: Not applicable.
: Dr. Welsh receives funding from The Family of M. Adnan Hamed; The Susan and Peter Goodwin Foundation; Mabuchi Research fund; the Weigand Foundation; and The Orr Family Foundation (to MD Anderson Cancer Center’s Thoracic Radiation Oncology program). Dr. Lin has grants from Genentech, Hitachi Chemical Diagnostics, New River Labs, Peregrine, BeyondSpring Pharmaceuticals, and STCube Pharmaceuticals and is on the advisory board for AstraZeneca.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.